Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis

被引：0
|
作者：
Qiu-Feng He
Qiong-Fang Zhang
Da-Zhi Zhang
机构：
[1] Chongqing Medical University,Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital
来源：
Digestive Diseases and Sciences | 2016年 / 61卷
关键词：
Genotype 1 hepatitis C; Sofosbuvir; Ledipasvir; Ribavirin; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3108 / 3117
页数：9
相关论文
共 50 条
  • [31] Safety and efficacy of once daily ledipasvir/sofosbuvir fixed-dose combination in patients with chronic hepatitis C
    Gamal, N.
    Andreone, P.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (04) : 549 - 557
  • [32] Retreatment Efficacy of Sofosbuvir/Ombitasvir/Paritaprevir/Ritonavir plus Ribavirin for Hepatitis C Virus Genotype 4 Patients
    Abdel-Moneim, Adel
    Aboud, Alaa
    Abdel-Gabbar, Mohamed
    Zanaty, Mohamed
    Ramadan, Mohamed
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (05) : 1341 - 1347
  • [33] Effectiveness and safety of community-based treatment with sofosbuvir plus ribavirin for elderly patients with genotype 2 chronic hepatitis C
    Atsukawa, Masanori
    Tsubota, Akihito
    Kondo, Chisa
    Shimada, Noritomo
    Abe, Hiroshi
    Kato, Keizo
    Okubo, Tomomi
    Arai, Taeang
    Itokawa, Norio
    Iio, Etsuko
    Tanaka, Yasuhito
    Iwakiri, Katsuhiko
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (09) : 1029 - 1035
  • [34] Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis
    Lim, Joseph K.
    Liapakis, Ann Marie
    Shiffman, Mitchell L.
    Lok, Anna S.
    Zeuzem, Stefan
    Terrault, Norah A.
    Park, James S.
    Landis, Charles S.
    Hassan, Mohamed
    Gallant, Joel
    Kuo, Alexander
    Pockros, Paul J.
    Vainorius, Monika
    Akushevich, Lucy
    Michael, Larry
    Fried, Michael W.
    Nelson, David R.
    Ben-Ari, Ziv
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (11) : 1811 - +
  • [35] Efficacy and safety of telaprevir and boceprevir in patients with hepatitis C genotype 1: a meta-analysis
    Park, C.
    Jiang, S.
    Lawson, K. A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (01) : 14 - 24
  • [36] Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study
    Kawakami, Yoshiiku
    Ochi, Hidenori
    Hayes, Clair Nelson
    Imamura, Michio
    Tsuge, Masataka
    Nakahara, Takashi
    Katamura, Yoshio
    Kohno, Hiroshi
    Kohno, Hirotaka
    Tsuji, Keiji
    Takaki, Shintaro
    Mori, Nami
    Honda, Yohji
    Arataki, Keiko
    Takahashi, Shoichi
    Kira, Shinsuke
    Tamura, Toru
    Masuda, Kazunari
    Nakamura, Toshio
    Kikkawa, Masaya
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (04) : 548 - 556
  • [37] Safety and Efficacy of Sofosbuvir with Ribavirin® in Hepatitis C, Genotype 3 Patients with Cirrhosis: A Real-world Experience
    Butt, Nazish
    Akhar, Ali
    Abbasi, Amanullah
    Reema, Sehrish
    Bin Bagar, Jaffer
    Shaikh, Qurban Hussain
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (02)
  • [38] Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
    Baatarkhuu, Oidov
    Lee, Jae Seung
    Amarsanaa, Jazag
    Kim, Do Young
    Ahn, Sang Hoon
    Naranzul, Nyamsuren
    Enkhtuya, Damba
    Choijamts, Nagir
    Batbayar, Purev
    Otgonbayar, Radnaa
    Saruul, Bat-Ulzii
    Gantuul, Chuluunbaatar
    Gegeebadrakh, Baljinnyam
    Tuvshinbayar, Narangerel
    Badamsuren, Dorjgotov
    Ulzmaa, Galsan
    Otgonbold, Jamiyandorj
    Han, Kwang-Hyub
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (01) : 125 - 135
  • [39] Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study
    Kim, Young Min
    Kim, Suk Bae
    Song, Il Han
    Lee, Sae Hwan
    Kim, Hong Soo
    Lee, Tae Hee
    Kang, Young Woo
    Kim, Seok Hyun
    Lee, Byung Seok
    Chae, Hee Bok
    Song, Myeong Jun
    Jang, Ji Woong
    Ko, Soon Young
    Lee, Jae Dong
    CLINICAL AND MOLECULAR HEPATOLOGY, 2018, 24 (03) : 311 - 318
  • [40] The efficacy of sofosbuvir and ribavirin in patients with chronic hepatitis C virus genotype 2 infection
    Kwan, Byung Soo
    Shim, Sang Goon
    Yu, Kil Jong
    Cho, Dae Hyeon
    Oh, Ji Eun
    Jeong, Chang Wook
    Kim, Kwang Min
    Lee, Hyoun Soo
    Lee, Jung Won
    Lee, Dong Kyu
    Choi, Ik Sung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 439 - 439
12345